from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0670/end

LFCtreatmentdescriptionclass of inhibitor

-0.733

Amikacinug/mL Amikacintranslation

-0.789

Cap5-10ug/mL Capreomycintranslation

-0.892

Rox10-50 ug/mL Roxithromycintranslation

0.159

SM2-5 ug/mL Streptomycintranslation

0.282

Tet5-10 ug/mL Tetracyclinetranslation

-0.608

Rif0.2-5ug/mL Rifampicintranscription

-0.872

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.470

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.549

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.628

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.658

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.611

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.118

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.408

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.415

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.490

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.340

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.256

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.907

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.593

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.447

KCN5-20 ug/mL Potassium cyaniderespiration

0.312

NaN30.2-2 mM Sodium aziderespiration

0.971

Nigericin50 uM Nigericinrespiration

0.121

TRC10-150 ug/mL Triclosanrespiration

0.226

TRZ10-25 ug/mL Thioridazinerespiration

1.025

Valinomycin0.5-10 uM Valinomycinrespiration

-0.810

ZnSO42 mM ZnSO4respiration

0.517

menadione6-10 ug/mL Menadionerespiration

-0.494

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.482

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.698

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.113

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.951

NRP_1Non-replicating persistence stage 1dosRassociated

-0.013

Amp0.2mg/mL AmpicillincellWall

0.753

Cephalexin20-100 ug/mL CephalexincellWall

-0.627

Cerulenin0.32-5 ug/mL CerulenincellWall

0.046

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.139

EMB10-20 ug/mL EthambutolcellWall

0.183

Eta12-40 ug/mL EthionamidecellWall

0.300

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.233

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.279

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.471

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.294

BZA0.12 mg/mL BenzamidearomaticAmides

0.387

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.724

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.769

H2O24 mM hydrogen peroxideDNAdamaging

-0.298

Levo10 ug/mL LevofloxacinDNAdamaging

-0.212

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.319

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.324

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.523

UVUV-irradiationDNAdamaging

-0.388

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.474

Antimycin12.5-50 ug/mL Antimycin A?

-0.303

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.449

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.085

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.273

PA8240.2-2 ug/mL PA-824?

1.439

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.263

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.297

Verapamil50 uM Verapamil?

0.208

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.336

methoxatin10-20 ug/mL Methoxatin?